Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation: An International, Multi-institutional Evaluation of Safety, Efficacy and Early Outcomes.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 1 4 2020
medline: 27 1 2022
entrez: 1 4 2020
Statut: ppublish

Résumé

Evaluating the perioperative outcomes of minimally invasive (MIV) donor hepatectomy for adult live donor liver transplants in a large multi-institutional series from both Eastern and Western centers. Laparoscopic liver resection has become standard practice for minor resections in selected patients in whom it provides reduced postoperative morbidity and faster rehabilitation. Laparoscopic approaches in living donor hepatectomy for transplantation, however, remain controversial because of safety concerns. Following the recommendation of the Jury of the Morioka consensus conference to address this, a retrospective study was designed to assess the early postoperative outcomes after laparoscopic donor hepatectomy. The collective experience of 10 mature transplant teams from Eastern and Western countries was reviewed. All centers provided data from prospectively maintained databases. Only left and right hepatectomies performed using a MIV technique were included in this study. Primary outcome was the occurrence of complications using the Clavien-Dindo graded classification and the Comprehensive Complication Index during the first 3 months. Logistic regression analysis was used to identify risk factors for complications. In all, 412 MIV donor hepatectomies were recorded including 164 left and 248 right hepatectomies. Surgical technique was either pure laparoscopy in 175 cases or hybrid approach in 237. Conversion into standard laparotomy was necessary in 17 donors (4.1%). None of the donors died. Also, 108 experienced 121 complications including 9.4% of severe (Clavien-Dindo 3-4) complications. Median Comprehensive Complication Index was 5.2. This study shows favorable early postoperative outcomes in more than 400 MIV donor hepatectomy from 10 experienced centers. These results are comparable to those of benchmarking series of open standard donor hepatectomy.

Sections du résumé

OBJECTIVE
Evaluating the perioperative outcomes of minimally invasive (MIV) donor hepatectomy for adult live donor liver transplants in a large multi-institutional series from both Eastern and Western centers.
BACKGROUND
Laparoscopic liver resection has become standard practice for minor resections in selected patients in whom it provides reduced postoperative morbidity and faster rehabilitation. Laparoscopic approaches in living donor hepatectomy for transplantation, however, remain controversial because of safety concerns. Following the recommendation of the Jury of the Morioka consensus conference to address this, a retrospective study was designed to assess the early postoperative outcomes after laparoscopic donor hepatectomy. The collective experience of 10 mature transplant teams from Eastern and Western countries was reviewed.
METHODS
All centers provided data from prospectively maintained databases. Only left and right hepatectomies performed using a MIV technique were included in this study. Primary outcome was the occurrence of complications using the Clavien-Dindo graded classification and the Comprehensive Complication Index during the first 3 months. Logistic regression analysis was used to identify risk factors for complications.
RESULTS
In all, 412 MIV donor hepatectomies were recorded including 164 left and 248 right hepatectomies. Surgical technique was either pure laparoscopy in 175 cases or hybrid approach in 237. Conversion into standard laparotomy was necessary in 17 donors (4.1%). None of the donors died. Also, 108 experienced 121 complications including 9.4% of severe (Clavien-Dindo 3-4) complications. Median Comprehensive Complication Index was 5.2.
CONCLUSIONS
This study shows favorable early postoperative outcomes in more than 400 MIV donor hepatectomy from 10 experienced centers. These results are comparable to those of benchmarking series of open standard donor hepatectomy.

Identifiants

pubmed: 32224747
pii: 00000658-202201000-00025
doi: 10.1097/SLA.0000000000003852
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-174

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures: The authors have no conflicts of interest to declare.

Références

Houssin D, Vigouroux C, Filipponi F, et al. One liver for two: an experimental study in primates. Transplant Int 1988; 1:201–204.
Cherqui D, Emond JC, Pietrabissa A, et al. Segmental liver transplantation from living donors. Report of the technique and preliminary results in dogs. HPB Surg 1990; 2:189–204.
Raia S, Nery JR, Mies S. Liver transplantation from live donor. Lancet 1989; 8661:497.
Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322:1505–1507.
Yamaoka Y, Washida M, Honda K, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994; 57:1127–1130.
Lo CM, Fan ST, Liu CL, et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997; 226:261–269.
Muzaale AD, Dagher NN, Montgomery RA, et al. Estimates of early death, acute liver failure, and long term mortality among live liver donors. Gastroenterology 2012; 142:273–280.
Cheah YL, Simpson MA, Pomposelli JJ, et al. Incidence of death and life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transplant 2013; 19:499–506.
Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008; 135:468–476.
Adcock L, Macleod C, Dubay D, et al. The university of Toronto liver transplant experience. Am J Transplant 2010; 10:364–371.
Iida T, Ogura Y, Oike F, et al. Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010; 89:1276–1282.
Abecassis MM, Fisher RA, Olthoff KM, et al. Complications of living donor hepatic lobectomy. A comprehensive report. Am J Transplant 2012; 12:1208–1217.
Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg 2015; 261:619–629.
Ciria R, Cherqui D, Geller DA, et al. Comparative short-term benefits of laparoscopic liver resection: 9,000 cases and climbing. Ann Surg 2016; 263:761–777.
Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, et al. Laparoscopic versus open resection for colorectal liver metastases: the OSLO-COMET randomized controlled trial. Ann Surg 2018; 267:199–207.
Cherqui D, Soubrane O, Husson E, et al. Laparoscopic living donor hepatectomy for liver transplantation in children. Lancet 2002; 359:392–396.
Soubrane O, Cherqui D, Scatton O, et al. Laparoscopic left lateral sectionectomy in living donors: safety and reproducibility of the technique in a single centre. Ann Surg 2006; 244:815–820.
Koffron AJ, Kung R, Baker T, et al. Laparoscopic-assistedright lobe donor hepatectomy. Am J Transplant 2006; 6:2522–2525.
Kurosaki I, Yamamoto S, Kitami C, et al. Video-assisted living donor hemihepatectomy through a 12-cm incision for adult-to-adult liver transplantation. Surgery 2006; 139:695–703.
Baker TB, Jay CL, Ladner DP, et al. Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes. Surgery 2009; 146:817–825.
Takahara T, Wakabayashi G, Hasegawa Y, et al. Minimally invasive donor hepatectomy: evolution from hybrid to pure laparoscopic technique. Ann Surg 2015; 261:e3–e4.
Suh KS, Yi NJ, Kim T, et al. Laparoscopy-assisted donor right hepatectomy using a hand port system preserving the middle hepatic vein branches. World J Surg 2009; 33:526–533.
Soubrane O, Perdigao-Cotta F, Scatton O. Pure laparoscopic right hepatectomy in a living donor. Am J Transplant 2013; 13:2467–2471.
Rotellar F, Pardo F, Benito A, et al. Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant 2013; 13:3269–3273.
Han HS, Cho JY, Yoon YS, et al. Total laparoscopic living donor right hepatectomy. Surg Endosc 2015; 29:184.
Samstein B, Cherqui D, Rotellar F, et al. Totally laparoscopic full left hepatectomy for living donor liver transplantation in adolescents and adults. Am J Transplant 2013; 13:2462–2466.
Troisi RI, Wojcicki M, Tomassini F, et al. Pure laparoscopic full-left living donor hepatectomy for calculated small-for-size LDLT in adults: proof of concept. Am J Transplant 2013; 13:2472–2478.
Rotellar F, Pardo F, Benito A, et al. Totally laparoscopic right hepatectomy for living donor liver transplantation. Analysis of a preliminary experience on 5 consecutive cases. Transplantation 2016; 101:548–554.
Kim KH, Kang SH, Jung DH, et al. Initial outcomes of pure laparoscopic donor right hepatectomy in an experienced adult living donor liver transplant center. Transplantation 2016; 101:1106–1110.
Takahara T, Wakabayashi G, Nitta H, et al. The first comparative study of the perioperative outcomes between pure laparoscopic donor hepatectomy and laparoscopy-assisted donor hepatectomy in a single institution. Transplantation 2017; 101:1628–1636.
Baker TB. Living liver donation, donor safety, and social media: preparing for a new frontier. Liver Transpl 2017; 23:131–132.
Soubrane O. Laparoscopic donor hepatectomy: the long and winding road. Transplantation 2017; 101:900–901.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250:187–196.
Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index. A novel continuous scale to measure surgical morbidity. Ann Surg 2013; 258:1–7.
Slankamenac K, Nederlof N, Pessaux P, et al. The comprehensive complication index. A novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg 2014; 260:757–763.
Eguchi S, Soyama A, Hara T, et al. Standardized hybrid living donor hemihepatectomy in adult-to-adult living donor liver transplantation. Liver Transplant 2018; 24:363–368.
Soubrane O, Kwon CHD. Tips for pure laparoscopic right hepatectomy in the live donor. J Hepatobiliary Pancreat Sci 2017; 24:E1–E5.
Ida T, Ogura Y, Oike F, et al. Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010; 89:1276–1282.
Abecassis M, Fisher RA, Olthoff KM, et al. Complications of living donor hepatic lobectomy: a comprehensive report. Am J Transplant 2012; 12:1208–1217.
Rössler F, Sapisochin G, Song GW, et al. Defining benchmarks for major liver surgery: a multicenter analysis of 5202 living liver donors. Ann Surg 2016; 264:492–500.
Lee JG, Lee KW, Kwon CHD, et al. Donor safety in living donor liver transplantation: the Korean organ transplantation registry study. Liver Transplant 2017; 23:999–1006.
Yoh T, Cauchy F, Kawai T, et al. Laparoscopic right hepatectomy using the caudal approach is superior to open right hepatectomy with anterior approach and liver hanging maneuver: a comparison on short-term outcomes. Surg Endosc 2019; 34:636–645.
Pravisani R, Takatsuki M, Baccarani U, et al. Pure laparoscopic donor right hepatectomy: exploring the dark side of the moon. Laparosc Surg 2018; 2:1–4.
Makki K, Chorasiya VK, Sood G, et al. Laparoscopy-assisted hepatectomy versus conventional (open) hepatectomy for living donors: when you know better, you do better. Liver Transpl 2014; 20:1229–1236.
Shirabe K, Eguchi S, Okajima H, et al. Current status of surgical incisions used in donors during living related liver transplantation: a nationwide survey in Japan. Transplantation 2018; 102:1293–1299.
Kitajima T, Kaido T, Iida T, et al. Short-term outcomes of laparoscopy-assisted hybrid living donor hepatectomy: a comparison with the conventional open procedure. Surg Endosc 2017; 31:5101–5110.
Humphreville VR, Radosevich DM, Humar A, et al. Longterm health-related quality of life after living liver donation. Liver Transplant 2016; 22:53–62.
Cauchy F, Fuks D, Nomi T, et al. Risk factors and consequences of conversion in laparoscopic major liver resection. Br J Surg 2015; 102:785–795.
Halls MC, Cipriani F, Berardi G, et al. Conversion for unfavorable intraoperative events results in significantly worse outcomes during laparoscopic liver resection: lessons learned from a multicenter review of 2861 cases. Ann Surg 2018; 268:1051–1057.
Lauterio A, Si Sandro S, Gruttadauria S, et al. Donor safety in living donor liver donation: an Italian multicenter survey. Liver Transpl 2017; 23:184–193.
Lee KW, Hong SK, Suh KS, et al. One hundred fifteen cases of pure laparoscopic living donor right hepatectomy at a single center. Transplantation 2018; 102:1878–1884.
Suh KS, Hong SK, Lee KW, et al. Pure laparoscopic living donor hepatectomy: focus on 55 donors undergoing right hepatectomy. Am J Transplant 2018; 18:434–443.
Kwon CHD, Choi GS, Kim JM, et al. Results of consecutive 54 cases of purely laparoscopic donor hepatectomy for adult living donor liver transplantation recipients. Liver Transpl 2018; 24:1545–1553.
Shehta A, Lee JM, Lee KW, et al. Pure laparoscopic living donor hepatectomy for donors with right portal vein anatomical variations. Liver Transpl 2019; 25:1445–1454.

Auteurs

Olivier Soubrane (O)

Department of HPB Surgery and Liver Transplant, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris and University of Paris, France.

Susumu Eguchi (S)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Shinji Uemoto (S)

Department of HBP Surgery & Transplantation, Kyoto University, Graduate School of Medicine, Kyoto, Japan.

Choon Hyuck David Kwon (CHD)

Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, OH.

Go Wakabayashi (G)

Center for Advanced Treatment of HBP Diseases, Ageo Central General Hospital, Tokyo, Japan.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Ki-Hun Kim (KH)

Division of Hepatobiliary surgery and Liver transplantation, Department of Surgery, Ulsan University and Asan Medical Center, Seoul, Republic of Korea.

Roberto Ivan Troisi (RI)

Department of Human Structure and Repair, Ghent University Faculty of Medicine, Belgium.
Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Daniel Cherqui (D)

Centre Hépato-Biliaire, Paul Brousse Hospital, Villejuif, Assistance Publique - Hôpitaux de Paris, and Paris Saclay University, France.

Fernando Rotellar (F)

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

François Cauchy (F)

Department of HPB Surgery and Liver Transplant, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris and University of Paris, France.

Akihiko Soyama (A)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Satoshi Ogiso (S)

Department of HBP Surgery & Transplantation, Kyoto University, Graduate School of Medicine, Kyoto, Japan.

Gyu-Seong Choi (GS)

Department of General Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.

Takeshi Takahara (T)

Department of Surgery, Iwate Medical University School of Medicine, Morioka, Iwate, Japan.

Jai Young Cho (JY)

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Hwui-Dong Cho (HD)

Division of Hepatobiliary surgery and Liver transplantation, Department of Surgery, Ulsan University and Asan Medical Center, Seoul, Republic of Korea.

Aude Vanlander (A)

Department of Human Structure and Repair, Ghent University Faculty of Medicine, Belgium.

Gabriella Pittau (G)

Centre Hépato-Biliaire, Paul Brousse Hospital, Villejuif, Assistance Publique - Hôpitaux de Paris, and Paris Saclay University, France.

Olivier Scatton (O)

Department of Surgery and Liver Transplant, Pitié Hospital, Assistance Publique - Hôpitaux de Paris and Sorbonne University of Paris, France.

Fernando Pardo (F)

Department of General Surgery, Clínica Universidad de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

Talia Baker (T)

Department of Surgery, Section of Transplant Surgery, University of Chicago, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH